There are 2789 resources available
345MO - Treatment associated changes in the inflammatory microenvironment composition of brain metastases
Presenter: Ariane Steindl
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
346MO - Safety of idroxioleic acid in combination with standard of care (temozolomide and/or radiation therapy) in newly diagnosed glioblastoma patients: A phase Ib trial
Presenter: Carme Balaña
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
347MO - 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial
Presenter: Nader Sanai
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
LBA12 - Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial
Presenter: Giampaolo Bianchini
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
120MO - Prognostic value of immune gene-expression signatures (iGES) vs tumor-infiltrating lymphocytes (TILs) in early-stage HER2+ breast cancer: A combined analysis of CALGB 40601 (C40601) and PAMELA trials
Presenter: Aranzazu Fernandez-Martinez
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA14 - Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) + palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study
Presenter: Sara Hurvitz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
121MO - Acute toxicity associated with a 3-week versus a standard 5-week regimen for locoregional breast radiotherapy delivered in the UNICANCER HypoG-01 phase III trial
Presenter: Sofia Rivera
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
122MO - Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib
Presenter: José García-Saenz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
123MO - BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Presenter: Peter Schmid
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
1038MO - Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
Presenter: Ivan Marquez-Rodas
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast